Order Menu

News

IDT premieres leading NGS lineup and expertise in Europe
Full story »
IDT launches ultra-high performance CRISPR Cas12a enzyme
Full story »
IDT brings unmatched customization to NGS
Full story »
IDT and iGEM partnership helps young researchers break free and innovate in synthetic biology
Full story »
IDT lowers genomic barriers with powerful rhAmpSeq™ targeted sequencing system
Full story »
IDT expands free next-day delivery service
Full story »
IDT backs innovative synthetic biology start-ups with grant awards
Full story »
Scientists vote IDT best-in-class for customer experience
Full story »
Correcting sickle cell–causing mutation with efficient CRISPR-Cas9 genome editing
Full story »
Danaher to acquire Integrated DNA Technologies
Full story »
IDT announces winners of the IDT Sustainability Award Supporting Innovation in Biodiversity Research
Full story »
Aldevron to provide new GMP Cas9 nuclease through agreement with Integrated DNA Technologies
Full story »
Integrated DNA Technologies acquires oligo manufacturing business of GeneWorks (Australia)
Full story »
IDT launches its RxnReady Oligo service
Full story »
IDT launches its first cancer panel
Full story »
IDT launches first Cas9 enzyme that drastically reduces CRISPR off-target effects without significant loss of on-target activity
Full story »
IDT partners with Illumina for NGS library preparation multiplexing and target enrichment
Full story »
Integrated DNA Technologies appoints LubioScience as distributors in Switzerland
Full story »
IDT Sustainability Award supports biodiversity research for second year
Full story »
IDT first to market with complete Cpf1-based CRISPR genome editing system
Full story »

Upcoming events

BIO World Congress on Industrial Biotechnology

8 July, 2019-11 July, 2019, Des Moines
Next Generation Dx Summit

20 August, 2019-22 August, 2019, Washington DC
The Global Synthetic Biology Summit

1 October, 2019-3 October, 2019, San Francisco

News

IDT premieres leading NGS lineup and expertise in Europe

IDT launches ultra-high performance CRISPR Cas12a enzyme

IDT brings unmatched customization to NGS

IDT and iGEM partnership helps young researchers break free and innovate in synthetic biology

IDT lowers genomic barriers with powerful rhAmpSeq™ targeted sequencing system

IDT expands free next-day delivery service

IDT backs innovative synthetic biology start-ups with grant awards

Scientists vote IDT best-in-class for customer experience

Correcting sickle cell–causing mutation with efficient CRISPR-Cas9 genome editing

Danaher to acquire Integrated DNA Technologies

IDT announces winners of the IDT Sustainability Award Supporting Innovation in Biodiversity Research

Aldevron to provide new GMP Cas9 nuclease through agreement with Integrated DNA Technologies

Integrated DNA Technologies acquires oligo manufacturing business of GeneWorks (Australia)

IDT launches its RxnReady Oligo service

IDT launches its first cancer panel

IDT launches first Cas9 enzyme that drastically reduces CRISPR off-target effects without significant loss of on-target activity

IDT partners with Illumina for NGS library preparation multiplexing and target enrichment

Integrated DNA Technologies appoints LubioScience as distributors in Switzerland

IDT Sustainability Award supports biodiversity research for second year

IDT first to market with complete Cpf1-based CRISPR genome editing system

Upcoming events

BIO World Congress on Industrial Biotechnology

Next Generation Dx Summit

The Global Synthetic Biology Summit

Company

Products

Support

Education

Tools